repository
BROWSE
Cited 0 times in 
Which Gene is a Dominant Predictor of Response during FOLFOX Chemotherapy for the Treatment of Metastatic Colorectal Cancer, MTHFR or XRCC1 Gene?
- Other Title
- 다제 병합요법이 시행된 전이성 대장암 환자에서 XRCC1 유전자 및 MTHFR 유전자 변이와 약물반응과의 관계
- Authors
- 김, 주형
- Advisor
- 서, 광욱
- Department
- 대학원 의학과
- Degree
- Doctor (2006)
- Appears in Collections:
- Theses > School of Medicine / Graduate School of Medicine > Doctor
- Full Text Link
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
